MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 93 filers reported holding MEI PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $86,000 | -61.4% | 142,987 | +70.9% | 0.00% | – |
| Q4 2021 | $223,000 | +298.2% | 83,650 | +310.7% | 0.00% | – |
| Q3 2021 | $56,000 | -42.3% | 20,366 | -40.4% | 0.00% | – |
| Q2 2021 | $97,000 | +42.6% | 34,192 | +71.8% | 0.00% | – |
| Q1 2021 | $68,000 | +41.7% | 19,903 | +9.4% | 0.00% | – |
| Q4 2020 | $48,000 | -34.2% | 18,196 | -22.4% | 0.00% | – |
| Q3 2020 | $73,000 | -65.9% | 23,449 | -54.7% | 0.00% | – |
| Q2 2020 | $214,000 | +164.2% | 51,759 | +2.6% | 0.00% | – |
| Q1 2020 | $81,000 | -66.9% | 50,453 | -49.0% | 0.00% | – |
| Q4 2019 | $245,000 | +255.1% | 98,897 | +139.6% | 0.00% | – |
| Q3 2019 | $69,000 | – | 41,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |